Nawi, Alban N.

HRN: 29-39-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
CEFUROXIME 750MG (VIAL)
07/30/2026
08/05/2026
IV
380mg
Q8
Scald Burn
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: